Latest week
10 Jul 2026
Close
3.700000
Fair value
2.038667
Next-week expectancy
Undecided 47.66%
Sharemaestro

NANEXA Chart Pack

Nanexa AB (publ)

Exchange
STO
Latest week
10 Jul 2026
Close
3.700000
Fair value
2.038667
Next-week expectancy
Undecided 47.66%
Generated
17 Jul 2026 12:20
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Chart Summary

Over the latest 12 completed weeks ending 2026-07-10, NANEXA fell 0.13%, moving from 3.71 to 3.70. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 11 of the last 12 weeks. Relative Strength is 10.67 and has softened across the 12-week window. Market Dynamics is -0.66 on the latest week. Next-week expectancy is undecided at 47.66% based on similar historical setup states.

Key Points

Week Ending
10 Jul 2026
Latest Close
3.70
12-Week Change
-0.13%
Trend Signal
Inactive
Next-Week Expectancy
Undecided 47.66%
Signal Weeks
11 of 12
Vs Trend Line
Below
Vs Fair Value
Above
Relative Strength
10.67
Market Dynamics
-0.66

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
10 Jul 2026
Latest Close
3.70
12-Week Change
-0.13%
Trend Signal
Inactive
Next-Week Expectancy
Undecided 47.66%
Signal Weeks
11 of 12
Vs Trend Line
Below
Vs Fair Value
Above
Relative Strength
10.67
Market Dynamics
-0.66

Over the latest 12 completed weeks ending 2026-07-10, NANEXA fell 0.13%, moving from 3.71 to 3.70. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 11 of the last 12 weeks. Relative Strength is 10.67 and has softened across the 12-week window. Market Dynamics is -0.66 on the latest week. Next-week expectancy is undecided at 47.66% based on similar historical setup states.

Industry Peers

Sweden equities in Drug Manufacturers - Specialty & Generic

Stock Exchange Week Open High Low Close Change
NEWBRY Newbury Pharmaceuticals AB (publ) STO 10 Jul 2026 2.06 2.50 1.22 2.42 17.48%
ENZY Enzymatica AB (publ) STO 10 Jul 2026 2.27 2.60 2.21 2.48 9.25%
CINPHA Cinclus Pharma Holding AB (publ) STO 10 Jul 2026 11.28 12.20 11.18 11.98 6.21%
ACUC AcuCort AB STO 10 Jul 2026 0.62 0.67 0.60 0.64 3.23%
MOB Moberg Pharma AB (publ) STO 10 Jul 2026 9.45 9.73 9.23 9.47 0.21%
PMED PEPTONIC Medical AB STO 10 Jul 2026 0.00 0.00 0.00 0.00 0.00%
VIVE Vivesto AB STO 10 Jul 2026 8.50 9.18 8.10 8.45 -0.59%
EQL EQL Pharma AB STO 10 Jul 2026 23.60 24.30 22.30 23.35 -1.06%
SOBI Swedish Orphan Biovitrum AB (publ) STO 10 Jul 2026 480.00 487.00 470.60 471.20 -1.83%
KLAR Klaria Pharma Holding AB (publ.) STO 10 Jul 2026 0.78 0.85 0.74 0.76 -2.31%
BIOG-B BioGaia AB (publ) STO 10 Jul 2026 120.20 121.50 116.50 116.50 -3.08%
ORX Orexo AB (publ) STO 10 Jul 2026 24.40 25.35 22.50 23.20 -4.92%
CRNO-B Cereno Scientific AB (publ) STO 10 Jul 2026 5.13 5.21 4.70 4.83 -5.93%
ALVO-SDB Alvotech SDB STO 10 Jul 2026 35.80 36.45 32.30 33.55 -6.28%
DICOT Dicot Pharma AB STO 10 Jul 2026 0.21 0.21 0.18 0.19 -7.16%
ODI ODI Pharma AB STO 10 Jul 2026 2.56 3.00 2.12 2.30 -10.16%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.